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Abstract: COVID-19 also affects pregnant and breastfeeding women. Hence, clinicians and
policymakers require reliable evidence on COVID-19 epidemiology and consequences in this
population. We aimed to assess the susceptibility of pregnant women to SARS-CoV-2 and women’s
perceived impact of the pandemic on their breastfeeding practices, medical counseling and social
support. We performed a cross-sectional study using an online survey in primary care in Belgium.
Pregnant and breastfeeding women and women who breastfed in the preceding four weeks were
eligible to participate. The survey was distributed through social media in April 2020. In total,
6470 women participated (i.e., 2647 pregnant and 3823 breastfeeding women). Overall, 0.3% of all
respondents reported to have tested positive for SARS-CoV-2, not indicating a higher susceptibility
of pregnant women to contracting COVID-19. More than 90% refuted that the pandemic affected
their breastfeeding practices, nor indicated that the coronavirus was responsible for breastfeeding
cessation. Half of the women even considered giving longer breastmilk because of the coronavirus.
In contrast, women’s medical counseling and social support were negatively affected by the lockdown.
Women without previous breastfeeding experience and in the early postpartum period experienced a
higher burden in terms of reduced medical counseling and support. In the future, more consideration
and alternative supportive measures such as tele-visits by midwives or perinatal organizations are
required for these women.
Keywords: COVID-19; SARS-CoV-2; pregnancy; breastfeeding; counseling; social support;
community health services; public health; primary health care; Belgium
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1. Introduction
In December 2019, the first cases of COVID-19 were identified in Wuhan, China [1]. On 11th
March 2020, the World Health Organization declared this global health emergency as a pandemic [2].
In Belgium, the first case of COVID-19 was identified on 3rd February 2020. Due to the exponential
increase in the number of affected people, hospitalizations and deaths, the Belgian government imposed
strict containment and social isolation measures (i.e., lockdown) from 18th March 2020 onwards.
Similar to other populations, pregnant and breastfeeding women encounter SARS-CoV-2 and
might contract COVID-19 [3]. However, given the unique situation of pregnancy and breastfeeding,
perinatal COVID-19 entails the risk of affecting the (unborn) infant [4]. Unfortunately, due to the
novelty of SARS-CoV-2, little is known about the susceptibility of pregnant women to the virus [5,6].
Nevertheless, this information is critical, particularly as the previous coronaviruses SARS and MERS
have been associated with severe fetal–maternal complications [7,8]. From a theoretical perspective,
pregnant women are more susceptible to respiratory pathogens and the development of severe
pneumonia due to the changes in their immune system [9]. So far, mainly case-reports and case-series
have been published concerning COVID-19 in the perinatal period [3,10–13], preventing the calculation
of risk estimates. In addition, most studies have focused on hospitalized patients, although a maximum
of one in five of COVID-19 patients in the general population require hospital admission [14]. Hence,
limiting research initiatives to hospital settings leads to an underuse of the research potential of
primary care.
Besides the potential impact of COVID-19 on fetal–maternal health, the emergence of a new and
highly contagious virus, including the unprecedented containment and social isolation measures,
might have created (exceptional) challenges for perinatal and child healthcare [15]. In Belgium, it is
common practice for pregnant women to consult with several types of health care professionals
(HCPs) throughout their pregnancy (i.e., obstetrician, midwife, general practitioner (GP) or medical
specialist). In the postpartum period, additional HCPs such as pediatricians or lactation consultants
and perinatal organizations play a role in the medical follow-up of the mother and child, help with
breastfeeding, taking care of the newborn and household support. To date, it is unknown to what
extent women’s access to health services and medical counseling has been affected by the imposed
restrictions in Belgium.
Overall, the challenges HCPs and policymakers face due to the pandemic require prompt solutions.
From an epidemiological perspective, insight into how many pregnant and breastfeeding women have
been infected with SARS-CoV-2 is required. At least as relevant, from a public health perspective,
evidence on the impact of the pandemic on breastfeeding practices, medical care and social support
is vital, including whether personal pregnancy and breastfeeding experiences are associated with
women’s self-reported burden. Understanding the consequences of the pandemic on fetal–maternal
health will not only contribute to reducing adverse events, but will also allow for the optimization of
the organization of perinatal healthcare during subsequent waves.
Therefore, the current study, performed in Belgian primary care, aimed to provide estimates
of SARS-CoV-2 infections among pregnant and breastfeeding women, as well as to assess women’s
perceived impact of the pandemic on their breastfeeding practices, medical counseling and social
support during pregnancy and lactation.
2. Methods
2.1. Study Design and Sample
A cross-sectional, observational study using an online, anonymous survey was conducted among
pregnant and breastfeeding women living in Belgium. The questionnaire was distributed in April 2020,
at least four weeks after the start of the lockdown in Belgium. All pregnant and breastfeeding women
and women who breastfed in the four weeks prior to the survey, older than 18 years, and understanding
Dutch or French were eligible to participate. A Dutch and French version of the survey was hosted on
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an online survey platform (i.e., Qualtrics) which participants could access by using a URL or QR code.
Ethical approval of the local Ethics Committee Research UZ/KU Leuven (S63966; 10 April 2020) and
online informed consent of all participants were obtained.
2.2. Survey
The survey was part of a large COVID-19 research project performed in Belgium and aimed
at promptly studying (1) the extent of SARS-CoV-2 infections among pregnant and breastfeeding
women; (2) women’s information needs about the coronavirus; (3) the impact of the pandemic and
lockdown on perinatal mental health, medication use and perceptions, breastfeeding practices, medical
counseling, and social support. The results on breastfeeding practices, medical counseling and social
support, along with COVID-19 epidemiology, are the subject of this paper. The surveys for pregnant
and breastfeeding women were quite similar, except for the questions on breastfeeding practices,
and were exploratory. In both surveys, COVID-19 epidemiology was studied by asking questions
which SARS-CoV-2 tests, test results and symptoms women had experienced in the preceding four
weeks. A pilot version of both surveys was tested by three women each and amendments were made
accordingly. Survey translation into French was performed by a professional translation office.
With regard to survey promotion, the URL, QR code, and posters to invite women were distributed
via the websites and social media accounts of perinatal organizations, patient and advocacy groups,
professional organizations of HCPs, as well as via popular pregnancy and breastfeeding fora and
Facebook groups. The Dutch version of the survey was available online between 10–19 April 2020;
the French version could be completed between 25 April and 3 May 2020.
2.3. Data Analysis
Survey results were analyzed using descriptive statistics with SPSS Statistics version 26 (IBM Corp,
Armonk, NY, USA ). All women who completed the breastfeeding survey, including those who recently
quit breastfeeding, were grouped into the category “breastfeeding women”. The breastfeeding duration,
as reported at the time of survey completion, was categorized into “≤6 weeks”, “between 6 weeks and
6 months”, and “>6 months”. Any formal degree obtained after a secondary school was considered
as “higher education”. With respect to COVID-19 diagnosis, women were categorized as COVID-19
case if they reported having received laboratory confirmation of SARS-CoV-2 infection, irrespective
of clinical signs and symptoms. Chi-square and Fisher’s exact tests (the latter in case requirements
for chi-square tests were not fulfilled) were used to determine whether personal pregnancy and
breastfeeding experiences (i.e., a previous pregnancy or breastfeeding experience and the categorized
duration of the current breastfeeding period) are associated with the self-reported impact of the
pandemic on medical counseling and social support. A 5% significance level was assumed for all tests.
3. Results
3.1. Characteristics of Study Participants
In total, 6470 women participated in the survey (2647 pregnant and 3823 breastfeeding women).
The mean age of the pregnant and breastfeeding women was 31 ± 4 years and 32 ± 4 years, respectively.
In total, 82% were highly educated, and 92% were professionally active (40% in healthcare). Primi- and
multigravida were equally represented among the pregnant respondents, while 12% were in the first
gestational trimester, 43% in the second trimester, and 45% in the third trimester. Of the breastfeeding
women, 54% already had previous breastfeeding experience. Overall, less than 10% of all respondents
reported to be involved in another COVID-19 research project. A detailed overview of the study
participants’ characteristics is shown in the Supplementary Materials (Table S1).
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3.2. SARS-CoV-2 Infections in the Study Sample
In total, only a few pregnant (3%) and breastfeeding women (4%) reported that they had been tested
for SARS-CoV-2 infection. The test positivity rate among pregnant and breastfeeding women was 13%
(n = 9) and 6% (n = 8), respectively (see Table 1). This corresponds to 0.3% of all study respondents who
tested positive for SARS-CoV-2. Only 1 of the 17 COVID-19 cases had been hospitalized. In addition,
0.5% of all respondents reported they were living together with someone who had tested positive for
SARS-CoV-2 in the preceding four weeks.
Table 1. Estimates of SARS-CoV-2 infection in the study sample.
Estimated Outcomes
Pregnancy Lactation
Total
(n = 2602)
Dutch
(n = 2303)
French
(n = 299)
Total
(n = 3817)
Dutch
(n = 3284)
French
(n = 533)
Respondents tested for SARS-CoV-2 2.7% (71) 2.5% (58) 4.3% (13) 3.7% (140) 3.3% (107) 6.2% (33)
Respondents tested positive for SARS-CoV-2 0.3% (9) 0.3% (7) 0.7% (2) 0.2% (8) 0.2% (5) 0.6% (3)
Test positivity rate in this sample 12.7% (9) 12.1% (7) 15.4% (2) 5.7% (8) 4.7% (5) 9.1% (3)
Hospitalized COVID-19 cases 11.1% (1) 0.0% (0) 50.0% (1) 0.0% (0) 0% (0) 0% (0)
Results are expressed as % (absolute numbers). “Dutch” and “French” refer to the language of the survey.
3.3. Self-Reported Symptoms of the COVID-19 Cases
The 17 COVID-19 cases mainly suffered from headache (n = 13), fever (n = 12),
anosmia/dysgeusia/anorexia (n = 11), and muscle pain (n = 11). Cough (n = 9) and shortness
of breath (n = 8) were also often reported. Overall, eight of the nine pregnant women with COVID-19
reported that the symptoms had a (rather) large influence on their functioning, while this was the case
for four of the eight breastfeeding women. A detailed overview of the self-reported symptoms of the
pregnant and breastfeeding COVID-19 cases is included in the Supplementary Materials (Table S2).
3.4. Impact on Breastfeeding Practices
Overall, 97% of the breastfeeding women were still breastfeeding at the time of survey completion.
Most breastfed infants were >6 months (42%) or between 6 weeks and 6 months (38%). Only one-fifth of
infants was ≤6 weeks (20%). Of the breastfed infants, 53% currently received mother’s milk exclusively.
In total, 91% of the breastfeeding women reported that the infant’s diet had not changed due to
the coronavirus pandemic. In case the diet had changed since the coronavirus outbreak, 82% cited that
their infants received more often breastmilk compared to the period preceding the pandemic. The main
reasons for this increase were that staying home with the infant (as a result of the lockdown) facilitated
breastfeeding, and the woman’s desire to protect her infant against coronavirus through breastmilk.
The main reasons for a decline in breastfeeding, as reported by the women, were a reduction in milk
production due to concerns about the virus, and the combination with other childcare responsibilities
at home.
Moreover, 88% of the few women who stopped breastfeeding in the four weeks prior to the survey
indicated that breastfeeding cessation was not caused by the coronavirus. In case the coronavirus was
considered responsible for breastfeeding cessation, women mainly attributed it to the consequences of
the lockdown (i.e., work from home along with other childcare responsibilities), a higher workload,
or reduced milk production due to concerns about the virus. In contrast, 97% of the breastfeeding
women had not considered (at all) to stop giving breastmilk due to the coronavirus. In fact, 55% had
already (strongly) considered as a result of the coronavirus to give breastmilk for a longer period of
time. Finally, 86% of the women with previous breastfeeding experience felt that the coronavirus had
(rather) no influence on how they personally dealt with breastfeeding.
3.5. Impact on Medical Counseling during Pregnancy and Lactation
In total, 86% of all pregnant respondents answered that their pregnancy was mainly followed-up
by an obstetrician, while a midwife and a GP were involved as the main HCP in the medical follow-up
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of 11% and 3% of the pregnant women, respectively. Importantly, 53% of the pregnant women indicated
that the coronavirus pandemic influenced their current pregnancy follow-up to some extent. Of those,
at least 60% reported having received less follow-up by midwives (65%) and obstetricians (62%)
compared to before the pandemic (see Table 2). Likewise, more than 40% cited that the pandemic
negatively influenced the extent of medical counseling by medical specialists (42%) and GPs (42%).
In contrast, less than 10% mentioned having received more follow-up by any type of HCP.
Table 2. Impact of the coronavirus pandemic on the extent of medical counseling during pregnancy
and lactation.
Health Care
Professional
More Follow-Up Less Follow-Up No Influence
Pregnancy Lactation Pregnancy Lactation Pregnancy Lactation
Obstetrician 3.5% (47) 3.6% (42) 61.8 (819) 63.5% (746) 34.7% (460) 32.9% (387)
Midwife 7.6 (74) 7.7% (103) 64.5 (627) 73.0% (981) 27.9% (271) 19.3% (260)
General practitioner 8.2 (70) 5.1% (52) 42.1 (360) 53.4% (547) 49.8% (426) 41.5% (425)
Medical specialist 3.8 (20) 3.2% (23) 42.4 (226) 49.4% (351) 53.8% (287) 47.4% (337)
Pediatrician N/A 4.8% (61) N/A 54.0% (689) N/A 41.2% (525)
Lactation consultant N/A 6.9% (57) N/A 59.3% (490) N/A 33.8% (279)
Perinatal organization N/A 3.9% (55) N/A 84.3% (1195) N/A 11.8% (168)
Results are expressed as % (absolute numbers). Percentages were calculated using as denominator the total
number of women who reported to be counseled by a specific type of health care professional during pregnancy or
breastfeeding. It is common practice in Belgium that pregnant and breastfeeding women have contact with different
groups of health care professionals. N/A = not applicable.
Furthermore, 43% of the breastfeeding women reported having experienced some impact of the
pandemic on the extent of medical counseling during the breastfeeding period. Of those, more than
50% answered to have received less counseling by any type of HCPs compared to before the pandemic
(see Table 2). In fact, the counseling by the official perinatal organizations focusing on the wellbeing of
newborns and breastfed infants was even more negatively affected (84%). In contrast, less than 10%
mentioned having received more follow-up by any type of HCP.
With regard to women’s personal experiences, current breastfeeding duration was associated with
the self-reported impact of the pandemic on medical counseling during breastfeeding. More specifically,
76% of the women who were breastfeeding for ≤6 weeks reported that the pandemic affected their
medical counseling, as compared to 56% of the women breastfeeding between 6 weeks and 6 months
and 18% of the women breastfeeding >6 months (p < 0.001). Likewise, women without breastfeeding
experience were more likely to report that the pandemic affected their medical counseling during
breastfeeding (49% vs. 38%; p < 0.001). In contrast, having a previous pregnancy experience was not
associated with the self-reported impact of the pandemic on medical counseling during pregnancy
(52% vs. 55%; p = 0.09).
3.6. Impact on Social Support during Lactation
In total, 39% of the breastfeeding women reported having experienced the impact of the pandemic
on the extent of social support they received during the breastfeeding period. Of those, women
indicated to have received less support from family (87%), friends (87%), perinatal organizations (86%),
and maternity assistance at home (68%) (see Table 3). Importantly, a substantial difference in the total
number of women reporting to have experienced the impact of the pandemic on social support was
observed according to the duration of breastfeeding (≤6 weeks: 73%; 6 w–6 m: 52%; >6 m: 12%;
p < 0.001). Moreover, women without breastfeeding experience were more likely to report that the
pandemic had an impact on social support during breastfeeding (45% vs. 34%; p < 0.001).
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Table 3. Impact of the coronavirus pandemic on the extent of social support during lactation.
Social Support Provided by More Support Less Support No Influence
Family 6.1% (85) 87.2% (1214) 6.7% (93)
Friends 4.6% (62) 87.2% (1179) 8.2% (111)
Perinatal organization 2.9% (37) 86.1% (1092) 11.0% (140)
Maternity assistance at home 5.8% (51) 67.5% (597) 26.8% (237)
Results are expressed as % (absolute numbers). Percentages were calculated using as denominator the total number
of women who indicated that a specific kind of support was applicable to them during the breastfeeding period.
4. Discussion
4.1. Main Findings
The current study aimed to provide estimates of SARS-CoV-2 infections among pregnant and
breastfeeding women, and to assess women’s perceived impact of the pandemic on their breastfeeding
practices, medical counseling and social support during pregnancy and lactation. Therefore, an online
survey was distributed through social media within the Belgian primary care setting a few weeks
after the start of the lockdown (i.e., at the peak of the first wave of the pandemic). At that time,
0.3% of the more than 6400 pregnant and breastfeeding women reported to have tested positive for
SARS-CoV-2. This percentage is substantially lower than the seroprevalence of 3–6% measured in the
general population in Belgium in April 2020 [16]. Importantly, the estimates observed in our sample
are undoubtedly underestimations of the actual prevalence due to the potential of an asymptomatic
course of COVID-19 in pregnancy and to the lack of systematic testing in Belgium at the time of
the survey completion [17,18]. However, even in the most extreme scenario when up to 85% of the
infected pregnant respondents were asymptomatic [17,18], and were thus not tested and diagnosed,
the seroprevalence of COVID-19 in our sample would not exceed the percentage observed in the
general population [16]. In addition, the test positivity rate in our pregnant sample, despite the limited
number of cases, is not higher than the rate obtained in the general population in the same period
(i.e., 15–25%) [19]. Hence, our results do not indicate a higher susceptibility of pregnant women to
contracting COVID-19. However, it cannot be ruled out that pregnant respondents imposed themselves
additional restrictions during the lockdown to further minimize the risk of infection.
Moreover, the small number of “confirmed” cases and the lack of outcome data prevented us
from drawing conclusions on the severity of COVID-19 in pregnancy. Although some authors declared
that pregnant women should not be considered a risk group for COVID-19 [20,21], other authors have
argued that more evidence is required prior to ruling out an increased risk of adverse outcomes of
COVID-19 in pregnancy [22,23]. Interestingly, and despite the subjectivity of the assessment and the
limited number of cases, eight of the nine pregnant respondents with COVID-19 reported that their
symptoms had a (rather) large influence on their functioning. This finding should at least remind us to
not trivialize the potentially harmful impact of COVID-19 in pregnancy. Since the outbreak of the virus,
several papers have been published on adverse outcomes of perinatal COVID-19, including miscarriage,
fetal distress, preterm delivery, and maternal and neonatal death [3,11,24,25]. Larger cohorts and
routine testing of all pregnant women are needed to correctly estimate the percentage of asymptomatic
women and to calculate reliable prevalence and risk estimates [17,26,27].
In our cohort, we did not observe a negative impact of the lockdown on self-reported breastfeeding
practices. Overall, more than 90% of the women refuted that the current situation affected the infant’s
diet, nor indicated that the coronavirus was responsible for breastfeeding cessation. In fact, half of
the women had (strongly) considered giving breastmilk for a longer period of time because of the
virus, pointing towards positive breastfeeding perceptions triggered by the COVID-19 pandemic.
Interestingly, house arrest during the lockdown could have had different effects on breastfeeding
practices. Being more often at home clearly facilitated breastfeeding for some women, while others
suffered from anxiety and stress due to concurrent childcare responsibilities. Hence, clinicians
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should be aware that the personal context and situation at home can affect women’s breastfeeding
practices differently.
Lastly, a substantial impact of the pandemic on medical counseling and support was observed,
in line with a recent report from the UK [28]. Although the counseling of all types of HCPs was affected
to some extent [29], the governmental perinatal organizations were most severely impacted by the
measures taken. This is not surprising at all given that their consultation offices had to be closed for
several weeks. Importantly, women without breastfeeding experience and in the early postpartum
period experienced a higher burden in terms of reduced medical counseling and support. Although the
latter finding is easy to understand given the higher number of consultations and support sessions
early after birth, the results should encourage HCPs and perinatal organizations to specifically focus
on both target groups in the future.
4.2. Methodological Considerations
Some strengths and limitations of the current study should be addressed. First, the study collected
more than 6400 responses in a short study period of 8–10 days. Of those, more than 90% reported to not
be involved in another COVID-19 research project, underlining that a large and unexplored perinatal
population was included in our study to investigate COVID-19 epidemiology and self-reported
consequences. As our study sample was collected in the primary care setting, it is likely that (severely)
ill and hospitalized women did not complete the survey, and hence, were not included in the estimates
of SARS-CoV-2 infections. However, the estimates observed in our sample would not be significantly
changed if the number of hospitalized pregnant women currently registered in the Belgian COVID-19
obstetric surveillance system was considered [30].
Furthermore, limitations inherent to a self-reported questionnaire distributed via social media
are applicable. Despite addressing a large and unexplored population living in all parts of Belgium,
selection bias might have occurred. Compared to population data, respondents were slightly older,
higher educated, and more professionally active, in particular in healthcare [31]. In addition,
an overrepresentation of women breastfeeding for more than 6 months was noted [32]. The inclusion of
this group of women with probably very positive feelings towards breastfeeding, along with the large
number of women working in healthcare and survey distribution via breastfeeding fora, might have led
to an underestimation of the impact of the COVID-19 pandemic on breastfeeding practices. However,
given the vast majority of women reporting to have not experienced an adverse impact on their
breastfeeding practices, it is plausible that our findings reflect the situation in the general breastfeeding
population. In any case, the results were collected in a high-income country with a specific perinatal
and child healthcare system. One should take into account that the results cannot simply be extended
to other countries or settings. Finally, the survey did not include questions assessing the impact of the
pandemic on social support during pregnancy; the study did also not provide comparisons with the
non-COVID era with regard to women’s personal context or situation at home.
4.3. Future Perspectives
The current study aimed to promptly answer urgent questions of the public, HCPs, researchers,
governmental perinatal organizations, and policymakers in Belgium with regard to the impact of
the pandemic on breastfeeding practices, medical counseling and social support. Due to the study
design, we were not able to collect data on breastfeeding initiation or duration among women who
delivered or were breastfeeding while the containment and social isolation measures were in place.
To assess the impact of these measures on breastfeeding initiation and duration, as compared to the
non-COVID era, the annual breastfeeding statistics for Belgium are eagerly awaited. Future studies
could also qualitatively investigate the breastfeeding intentions of mothers who delivered during the
pandemic. Given the impact of the lockdown on women’s support and perinatal mental health [33,34],
awareness of clinicians and governmental perinatal organizations is, however, required to ensure the
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emotional wellbeing of women and to safeguard perinatal and infant mental health in the wake of
the pandemic.
Overall, the results on the impact on medical counseling are informative for the Belgian context.
However, given the global spread of SARS-CoV-2 and the worldwide imposed restrictions, it might
be interesting to explore to what extent access to health services and social support has been affected
across countries where different containment measures were in place.
Finally, it is likely that the organization of the healthcare system in Belgium will undergo
sustainable transformations as a result of the pandemic, such as the expansion of telemedicine for
non-urgent care visits (e.g., by midwives), and the integration of telemonitoring and mobile health
applications in the follow-up of high-risk pregnancies [35–37]. It will be fascinating to monitor to what
extent these virtual transformations will be adopted by the perinatal and child healthcare system and
the public in Belgium. However, prior to nationwide implementation, a thorough investigation of the
experiences, preferences and needs of HCPs and the public, as well as of the potential barriers and
facilitators is required to ensure successful uptake across different disciplines and population groups.
5. Conclusions
In total, 0.3% of a cohort of pregnant and breastfeeding women residing in the primary care
setting of Belgium tested positive for SARS-CoV-2 at the peak of the first wave of the pandemic.
Although it cannot be ruled out that pregnant respondents imposed themselves additional restrictions
to minimize the risk of infection, our results do not point towards a higher susceptibility of pregnant
women to contracting COVID-19. Moreover, no negative impact of the lockdown on self-reported
breastfeeding practices was observed. In fact, positive breastfeeding perceptions triggered by the
coronavirus were cited by half of the women. In contrast, women’s medical counseling and social
support were negatively affected by the lockdown, mainly among women without breastfeeding
experience and in the early postpartum period. Hence, more consideration and alternative supportive
manners such as tele-visits by midwives or perinatal organizations are required for these women in
the wake of the pandemic and during subsequent waves.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/17/18/6766/s1,
Table S1: Characteristics of the study participants; Table S2: Self-reported symptoms of the COVID-19 cases during
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